Overview of Dr. Abramson
Dr. David Abramson is an ophthalmologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. Dr. Abramson received Dr. Abramsons medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 48 years. Dr. Abramson is experienced in retinoblastoma, orbital tumors, and intraocular melanoma. He is the first Chief of Ophthalmic Oncology at MSKCC where he is a tenured professor in Surgery, Pediatrics and Radiation oncology. He has published more than 800 articles which have been cited more than 20,000 times.
Office
1275 York Avenue
New York, NY 10065
Education & Training
- Albert Einstein College of MedicineClass of 1969
Certifications & Licensure
- NY State Medical License 1970 - 2026
- CO State Medical License 2000 - 2025
- MA State Medical License 1973 - 2019
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Lifetime Achievement Award American Academy of Ophthalmology, 2015
- Stallard Medal Cambridge University, 2015
- Heed Alumni Award Heed Foundation, 2012
- Join now to see all
Publications & Presentations
PubMed
- Ophthalmic Artery Chemosurgery for Retinoblastoma Babies Less than 3 months old or under 6 KG Weight.David H Abramson, Jasmine H Francis, Jared Knopman, Ira J Dunkel, Y Pierre Gobin
Ophthalmology. Retina. 2025-03-20 - Vitreoretinal lymphoma: the importance of cerebral spinal fluid evaluation at initial diagnosis.Rebecca F Silverman, David H Abramson, Julia Canestraro, Christian Grommes, Jasmine H Francis
The British Journal of Ophthalmology. 2025-03-20 - Machine learning demonstrates clinical utility in distinguishing retinoblastoma from pseudo retinoblastoma with RetCam images.Owen Cruz-Abrams, Ricardo Dodds Rojas, David H Abramson
Ophthalmic Genetics. 2025-01-20
Journal Articles
- Growth Patterns of Survivors of Retinoblastoma Treated with Ophthalmic Artery ChemosurgeryJasmine H Francis, Y Pierre Gobin, David H Abramson, PLoS One
- Total Retinal Detachments Due to Retinoblastoma: Outcomes Following Intra-Arterial chemotherapy/ophthalmic Artery ChemosurgeryIra J Dunkel, Jasmine H Francis, Y Pierre Gobin, Scott E Brodie, David H Abramson, PLoS One
Press Mentions
- Hearing Evaluations in Children with Retinoblastoma Treated with Intra-Arterial Carboplatin Chemotherapy: A Single Institution ReviewSeptember 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: